On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Lars Börnsen

ResearcherPublications, citations & collaboration network

Lars Börnsen is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Lars Börnsen have?

ScholarIQindexed works

Lars Börnsen has 40 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Lars Börnsen have?

ScholarIQcitation count

Lars Börnsen has 1,721 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Lars Börnsen?

ScholarIQh-index

Lars Börnsen has an h-index of 21 in OpenAlex.

What is the i10-index of Lars Börnsen?

ScholarIQi10-index

Lars Börnsen has an i10-index of 29 in OpenAlex.

What is the OpenAlex record for Lars Börnsen?

ScholarIQopenalex

The OpenAlex for Lars Börnsen is on the source record.

What are the most-cited papers on Lars Börnsen?

ScholarIQmost cited works
Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression
Jeppe Romme Christensen, Lars Börnsen, Rikke Ratzer, Fredrik Piehl, Mohsen Khademi, Tomas Olsson, Per Soelberg Sørensen, Finn Sellebjerg
PLoS ONE. 2013246 CitationsOPEN ACCESS
Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS
Finn Sellebjerg, Lars Börnsen, Mohsen Khademi, Martin Krakauer, Tomas Olsson, Jette Lautrup Frederiksen, Per Soelberg Sørensen
Neurology. 2009218 Citations
Natalizumab in progressive MS
Jeppe Romme Christensen, Rikke Ratzer, Lars Börnsen, Mark Lyksborg, Ellen Garde, Tim B. Dyrby, Hartwig R. Siebner, Per Soelberg Sørensen, Finn Sellebjerg
Neurology. 2014129 Citations
CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis
Jeppe Romme Christensen, Lars Börnsen, Mohsen Khademi, Tomas Olsson, Poul Erik Jensen, Per Soelberg Sørensen, Finn Sellebjerg
Multiple Sclerosis Journal. 201299 CitationsOPEN ACCESS
The effects of natalizumab on inflammatory mediators in multiple sclerosis: prospects for treatment‐sensitive biomarkers
Mohsen Khademi, Lars Börnsen, Farshid Rafatnia, Magnus Andersson, Lou Brundin, Fredrik Piehl, Finn Sellebjerg, Tomas Olsson
European Journal of Neurology. 200998 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · 14-day free trial